ZEGERID
NDC 68012-052, omeprazole and sodium bicarbonate, powder, for suspension, from Santarus, Inc...
- Product NDC
- 68012-052
- Status
- Listed
- Labeler
- Santarus, Inc..
- Dosage form
- POWDER, FOR SUSPENSION
- Route
- ORAL
- Product type
- HUMAN PRESCRIPTION DRUG
- Marketing category
- NDA
- Application
- NDA021636
- DEA schedule
- None
curl https://api.healthcare.dev/v1/drugs/ndc/68012-052 \ -H "Authorization: Bearer $HDEV_API_KEY"
Product
Active ingredients and packages
Active ingredients
- OMEPRAZOLE20 mg/1
- SODIUM BICARBONATE1680 mg/1
Pharmacologic classes
Alkalinizing Activity [MoA]; Cytochrome P450 2C19 Inhibitors [MoA]; Proton Pump Inhibitor [EPC]; Proton Pump Inhibitors [MoA]
| Package NDC | NDC-11 | Package |
|---|
Linked data
RxNorm, label and prices
RxNorm concepts
RxNorm links no concept to this product's packages.
Related lookups
FDA label sections
GET /v1/drugs/labels/cd6868b9-5824-442b-8d65-4db29ecb70a4
Use it
Look up 68012-052 from code or an agent
curl https://api.healthcare.dev/v1/drugs/ndc/68012-052 \ -H "Authorization: Bearer $HDEV_API_KEY"
Using the healthcare.dev MCP server, look up NDC 68012-052. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.
Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.